 Home > Medical News > Latest Medical News > GSK Central Nervous Drugs Approved in China for New Indications for Treatment of Bipolar Disorder

GSK Central Nervous Drugs Approved in China for New Indications for Treatment of Bipolar Disorder

 Last Update: 2021-03-23
 Source: Internet
 Author: User

Tags

mrna clinical trials

vibramycin generic name

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On March 3, GlaxoSmithKline (GSK) issued a press release stating that the new indications of Rapidone (generic name: Lamotrigine Dispersible Tablets) have been approved by the National Medical Products Administration (NMPA).

Bipolar disorder is a disease that can cause severe fluctuations in mood, vitality, and ability to perform daily tasks.

Lamotrigine is a voltage-based sodium channel blocker.

The results of two international phase 3 clinical trials for bipolar disorder showed that compared with placebo, lamotrigine significantly delayed the intervention of any affective episode for up to 197 days, and the effect was similar to that of lithium salt; it was different from lithium salt Compared with placebo, lamotrigine significantly delayed the intervention time to depressive episode.

According to the press release, GSK lamotrigine dispersible tablets have been approved for new indications for bipolar disorder, which will bring more treatment options for such patients, thereby helping to improve the quality of life and prognosis of patients.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.